Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2017-04-21

New medicine for rare neurodegenerative disorder in children

View source ↗

Summary

EMA announces a new medicine approved for a rare neurodegenerative disorder in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications